category,datetime,headline,id,image,related,source,summary,url
company,1769370180,Merck No Longer In Talks With Revolution Medicines: WSJ,138256385,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRK,Yahoo,"FEATURE  Merck is no longer in discussions to buy biotech Revolution Medicines, according to people familiar with the matter.  Merck had recently been in talks to acquire RevMed in a deal that could have valued the cancer-drug biotech at around $30 billion.",https://finnhub.io/api/news?id=11bc68c51853a260c6f197a7227e9856586713ad37d4aabd3341da132f9e8e5b
company,1769369400,Merck No Longer in Talks to Buy Revolution Medicines,138255814,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRK,Yahoo,The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at around $30 billion.,https://finnhub.io/api/news?id=74963da0a739cd961bc2048f9d6302aa8740314f42280ba3be555461423928f0
company,1769350469,"Merck & Co., Inc. (MRK) and CEPI Launch Effort to Make Ebola Vaccine Cheaper and Easier to Distribute",138253962,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRK,Yahoo,"Merck & Co., Inc. (NYSE:MRK) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported that Merck & Co., Inc. (NYSE:MRK)’s MSD unit and the Coalition for Epidemic Preparedness Innovations (CEPI) said on January 21 that they are launching a $30 million program to create an updated version of Merck’s Ebola vaccine. The idea […]",https://finnhub.io/api/news?id=54943889887df3aa7c10f6f77fbdd3017de82e302642b6367015e1359f615e76
company,1769334388,"Here Are the Top Four Blue-Chip Stocks To Buy in 2026, According to WarrenAI",138251856,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRK,Yahoo,"Investing.com -- Blue chip stocks in the healthcare sector are showing exceptional growth potential according to recent rankings from WarrenAI. The analysis highlights four standout companies that combine strong fundamentals with significant upside potential, making them attractive options in today’s market.",https://finnhub.io/api/news?id=50088ad55439c5b4aedc60b50ee2121ad41abaf7153f4d0918a7e8ad43ff779b
